RU94046310A - Эфиры никотиновой кислоты, способ их получения, способ получения промежуточных соединений, фармацевтическая композиция и способ лечения - Google Patents
Эфиры никотиновой кислоты, способ их получения, способ получения промежуточных соединений, фармацевтическая композиция и способ леченияInfo
- Publication number
- RU94046310A RU94046310A RU94046310/04A RU94046310A RU94046310A RU 94046310 A RU94046310 A RU 94046310A RU 94046310/04 A RU94046310/04 A RU 94046310/04A RU 94046310 A RU94046310 A RU 94046310A RU 94046310 A RU94046310 A RU 94046310A
- Authority
- RU
- Russia
- Prior art keywords
- synthesis
- compounds
- saturated
- electron
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Abstract
Описываются новые соединения формулы (П), где R выбран из насыщенных или ненасыщенных алкилов, насыщенных и ненасыщенных циклоалкилов, гетероциклических соединений или из групп (а) или (b) где G представляет углерод или азот; m равно 0 - 10; где R, Rи Rявляются одинаковыми или различными и выбраны из водорода, галоида, алкила, содержащего 1 - 5 атомов углерода, электронодонорных групп таких как, алкокси, содержащих 1 - 5 атомов углерода, или гидрокси, электроноакцепторных групп, выбранных из циано, нитро, фторалкила и их фармакологически активных солей. Новые соединения могут быть использованы для лечения расстройств центральной нервной системы.
Claims (1)
- Описываются новые соединения формулы (П), где R выбран из насыщенных или ненасыщенных алкилов, насыщенных и ненасыщенных циклоалкилов, гетероциклических соединений или из групп (а) или (b) где G представляет углерод или азот; m равно 0 - 10; где R1, R2 и R3 являются одинаковыми или различными и выбраны из водорода, галоида, алкила, содержащего 1 - 5 атомов углерода, электронодонорных групп таких как, алкокси, содержащих 1 - 5 атомов углерода, или гидрокси, электроноакцепторных групп, выбранных из циано, нитро, фторалкила и их фармакологически активных солей. Новые соединения могут быть использованы для лечения расстройств центральной нервной системы.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9201956-1 | 1992-06-25 | ||
| SE9201956A SE9201956D0 (sv) | 1992-06-25 | 1992-06-25 | Novel nicotinicacid esters |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU94046310A true RU94046310A (ru) | 1996-10-27 |
| RU2127732C1 RU2127732C1 (ru) | 1999-03-20 |
Family
ID=20386602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU94046310A RU2127732C1 (ru) | 1992-06-25 | 1993-06-23 | Эфиры бис-фенилпиперазинникотиновой кислоты, способ их получения (варианты), фармацевтическая композиция и способ лечения расстройств центральной нервной системы |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5658910A (ru) |
| EP (2) | EP1120410B1 (ru) |
| JP (1) | JP3306827B2 (ru) |
| KR (1) | KR100302216B1 (ru) |
| CN (1) | CN1085981C (ru) |
| AT (2) | ATE278671T1 (ru) |
| AU (1) | AU681346B2 (ru) |
| BG (1) | BG62000B1 (ru) |
| CA (1) | CA2139112C (ru) |
| CZ (1) | CZ281975B6 (ru) |
| DE (2) | DE69331234T2 (ru) |
| DK (1) | DK0673368T3 (ru) |
| EE (1) | EE03122B1 (ru) |
| ES (1) | ES2169044T3 (ru) |
| FI (1) | FI107151B (ru) |
| HU (2) | HU220613B1 (ru) |
| IL (1) | IL106135A (ru) |
| NO (1) | NO302945B1 (ru) |
| NZ (1) | NZ253823A (ru) |
| PH (1) | PH31417A (ru) |
| PT (1) | PT673368E (ru) |
| RO (1) | RO115725B1 (ru) |
| RU (1) | RU2127732C1 (ru) |
| SE (1) | SE9201956D0 (ru) |
| SK (1) | SK279393B6 (ru) |
| WO (1) | WO1994000434A1 (ru) |
| ZA (1) | ZA934596B (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6632823B1 (en) * | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
| DE69919707T2 (de) | 1998-06-19 | 2005-09-01 | Chiron Corp., Emeryville | Glycogen synthase kinase 3 inhibitoren |
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US11447480B2 (en) * | 2018-05-09 | 2022-09-20 | Lg Chem, Ltd. | Compound exhibiting enteropeptidase inhibitory activity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8701375D0 (sv) * | 1987-04-02 | 1987-04-02 | Leo Ab | Novel pyridyl- and pyrimidyl derivatives |
| SE9201239D0 (sv) * | 1992-04-21 | 1992-04-21 | Kabi Pharmacia Ab | Agents for treating substance abuse disorders |
| SE9202265D0 (sv) * | 1992-07-31 | 1992-07-31 | Kabi Pharmacia Ab | Novel- pyridyl and pyrimidylpiperazine derivatives |
-
1992
- 1992-06-25 SE SE9201956A patent/SE9201956D0/xx unknown
-
1993
- 1993-06-23 AT AT01108668T patent/ATE278671T1/de not_active IP Right Cessation
- 1993-06-23 DK DK93915075T patent/DK0673368T3/da active
- 1993-06-23 DE DE69331234T patent/DE69331234T2/de not_active Expired - Fee Related
- 1993-06-23 AU AU45193/93A patent/AU681346B2/en not_active Ceased
- 1993-06-23 HU HU9403786A patent/HU220613B1/hu not_active IP Right Cessation
- 1993-06-23 ES ES93915075T patent/ES2169044T3/es not_active Expired - Lifetime
- 1993-06-23 CZ CZ943274A patent/CZ281975B6/cs not_active IP Right Cessation
- 1993-06-23 SK SK1585-94A patent/SK279393B6/sk not_active IP Right Cessation
- 1993-06-23 DE DE69333655T patent/DE69333655D1/de not_active Expired - Lifetime
- 1993-06-23 CA CA002139112A patent/CA2139112C/en not_active Expired - Fee Related
- 1993-06-23 AT AT93915075T patent/ATE209634T1/de not_active IP Right Cessation
- 1993-06-23 NZ NZ253823A patent/NZ253823A/en not_active IP Right Cessation
- 1993-06-23 JP JP50226894A patent/JP3306827B2/ja not_active Expired - Fee Related
- 1993-06-23 RO RO94-02087A patent/RO115725B1/ro unknown
- 1993-06-23 EP EP01108668A patent/EP1120410B1/en not_active Expired - Lifetime
- 1993-06-23 KR KR1019940704643A patent/KR100302216B1/ko not_active IP Right Cessation
- 1993-06-23 US US08/362,475 patent/US5658910A/en not_active Expired - Lifetime
- 1993-06-23 RU RU94046310A patent/RU2127732C1/ru not_active IP Right Cessation
- 1993-06-23 WO PCT/SE1993/000565 patent/WO1994000434A1/en active IP Right Grant
- 1993-06-23 EP EP93915075A patent/EP0673368B1/en not_active Expired - Lifetime
- 1993-06-23 PT PT93915075T patent/PT673368E/pt unknown
- 1993-06-24 IL IL10613593A patent/IL106135A/en not_active IP Right Cessation
- 1993-06-25 ZA ZA934596A patent/ZA934596B/xx unknown
- 1993-06-25 CN CN93116250A patent/CN1085981C/zh not_active Expired - Fee Related
-
1994
- 1994-11-17 EE EE9400400A patent/EE03122B1/xx not_active IP Right Cessation
- 1994-12-22 BG BG99289A patent/BG62000B1/bg unknown
- 1994-12-23 NO NO945022A patent/NO302945B1/no not_active IP Right Cessation
- 1994-12-23 FI FI946085A patent/FI107151B/fi active
-
1995
- 1995-05-23 HU HU95P/P00139P patent/HU210875A9/hu unknown
-
1998
- 1998-06-24 PH PH4640898A patent/PH31417A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2203274C2 (ru) | Спироциклические ингибиторы металлопротеаз | |
| RU95101430A (ru) | Производные 1-бифенилметилимидазола, их получение, фармацевтическая композиция, способ лечения или профилактики гипертонии | |
| RU94022743A (ru) | Амидо- или карбамидо-производные, обладающие антигиперхолестериновой активностью, и фармацевтическая композиция на их основе | |
| DE68914292D1 (de) | Zusammensetzung zur Behandlung von ischämischen Störungen in Organen. | |
| RU94045897A (ru) | Производные индола в качестве 5-hti-агонистов, фармацевтическая композиция и способ лечения | |
| LU88348I2 (fr) | Chlorhydrate d'esmolol (Brevibloc) | |
| KR960702442A (ko) | 타이로신 키나아제 억제인자로서의 치환된 β-아릴 및 β-헤테로아릴-α-시아노아크릴아미드 유도체(Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors) | |
| RU2220953C2 (ru) | Ненасыщенные производные гидроксимовой кислоты в качестве ингибиторов nadnad+ - adp-рибозилтрансферазы | |
| DE69329084D1 (de) | Benzoxazepin-Derivate als Cholinesterase-Inhibitoren | |
| RU94046310A (ru) | Эфиры никотиновой кислоты, способ их получения, способ получения промежуточных соединений, фармацевтическая композиция и способ лечения | |
| NO162283C (no) | Analogifremgangsmaate til fremstilling av nye terapeutisk,aktive substituerte 3-fenoksy-1-alkoksykarbonyl-alkylamino-propanoler-2. | |
| EA199700287A1 (ru) | Бензамиды для лечения нейродегенеративных заболеваний | |
| KR960022476A (ko) | 디페닐 디설파이드 화합물 | |
| FR2355839A1 (fr) | Derives optiquement actifs d'acide benzoxazolyl-propionique, procede pour leur preparation et compositions therapeutiques les contenant | |
| RU94036775A (ru) | Производные фенил-имидазолидинона, способ их получения, фармацевтическая композиция | |
| RU95105159A (ru) | 3-карбоксальдегидные производные хинолина и нафтиридина, антибактериальная композиция, способ лечения | |
| FR2418792A1 (fr) | Derives de 3-azabicyclo(3.1.0)hexane, procede pour leur preparation, compositions biologiquement actives les contenant et procede herbicide les utilisant | |
| RU95107154A (ru) | Производные 5,6-дигидро-4н-тиено[3,4-c]пиррола, их получение и содержащие их медикамент и фармацевтическая композиция | |
| ATE25968T1 (de) | 1,1-diphenylpropanol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| IT1304656B1 (it) | Derivati dell'acido retinoico per uso medicinale e relativometodo di preparazione. | |
| FR2633292B1 (fr) | Nouveaux derives de la 20,21-dinoreburnamenine substitues en 15 par un groupement amine, leur procede de preparation et les intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les reenfermant | |
| RU94026275A (ru) | Фармацевтические композиции для профилактики и/или лечения желудочно-кишечных заболеваний, включая язву | |
| RU94035756A (ru) | Производные имидазола, являющиеся ингибиторами питокинов, способы их получения, фармацевтическая композиция | |
| TH17758A (th) | สารเคมี | |
| GR28165B (el) | Μεθοδος δια την παραγωγην νεων ανορεκτικων προιοντων. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20100624 |